Introduction: Proper standardization of laboratory testing requires assessment of performance after the tests are performed, known as the postanalytical phase. A nationwide external quality assessment (EQA) scheme implemented in Croatia in 2014 includes a questionnaire on post-analytical practices, and the present study examined laboratory responses in order to identify current post-analytical phase practices and identify areas for improvement.
Introduction
Comparability of laboratory test results depends on standardization of all phases of laboratory testing, including pre-analytical, analytical and postanalytical phases. Pre-analytical and analytical phases of laboratory testing aim to generate an accurate test result, while the post-analytical phase -when the clinician receives the test results, interprets them, and uses them to make diagnostic and therapeutic decisions -aims to reduce errors or bias associated with the hand-off from laboratory to clinician. The most frequent errors in the post-analytical phase are erroneous validation of analytical data, failure to report test results to appropriate parties, excessively long turnaround time (TAT), mistakes in data entry, manual transcription errors and failure or delay in reporting critical values (1) .
Despite the obvious importance of the post-analytical phase to overall laboratory performance, many providers of external quality assessment (EQA) schemes do not take into account the postanalytical phase (2) . In 2009, the Croatian Chamber
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of Medical Biochemists (CCMB) and Croatian Society of Medical Biochemistry and Laboratory Medicine (CSMBLM) assessed the state of pre-and postanalytical procedures in medical laboratories across the country (3). The results indicated urgent, substantial need for improvement. Therefore, a nationwide EQA scheme covering the postanalytical phase was implemented in 2014, administered by the Croatian Centre for Quality Assessment in Laboratory Medicine (CROQALM) within the CSMBLM. The EQA scheme is implemented modularly three times per year. The CCMB made participation in the scheme mandatory for all medical laboratories in Croatia in 2013 (4) . In the second EQA exercise of 2014, pilot modules on pre-and post-analytical phases were introduced; in all three EQA exercises of 2015, Module 11 dealing with the post-analytical phase was performed.
The present study was undertaken to evaluate to what extent the recently introduced nationwide EQA scheme for the post-analytical phase of laboratory testing has influenced laboratory practice in Croatia. Since laboratories showed substantial variation in post-analytical practices before the scheme (3), we felt it necessary to evaluate the success of the EQA scheme at this early stage in order to identify the more important issues and implementation gaps and thereby help regulators and laboratory directors focus their energies more efficiently in the coming years. In a separate publication, we will assess pre-analytical procedures using an EQA module for the pre-analytical phase developed by the CSMBLM.
Module 11 is an educational module about the post-analytical phase of laboratory testing, and it contains an optional questionnaire that presents medical laboratories with routine post-analytical scenarios where standardized practices exist under the Croatian EQA scheme or where clear rules are lacking ('grey areas'). The present study retrospectively analysed laboratory responses to this questionnaire in 2014-2015 in order to (a) gain onthe-ground insights into current laboratory practices in Croatia and (b) identify the most urgent areas for improving the standardization of the postanalytical phase in Croatian laboratories. Data from all responding laboratories were used in the present study; no exclusion criteria were applied. When they filled out the questionnaire, laboratories gave consent for the data to be stored and used by CROQALM for group-level analyses. Members of CROQALM signed statements that they would safeguard the confidentiality of EQA data.
Materials and methods
Study design
Questionnaire
Questionnaires have been proposed as an effective method for assessing the post-analytical phase during EQA exercises (2 
Data analysis
Data were not analysed statistically. Instead, results were reported as absolute numbers and percentages.
Results
The number of medical laboratories participating in each exercise varied, as did the number that filled out the questionnaire; Figure 1 presents a histogram of response rates to questions. The response rate was always more than 80% of laboratories participating in the exercise. On the other hand, the laboratories showed sub- a) telephone the physician immediately after the analysis, inform him or her about glucose concentration (recommended critical value for glucose is < 2.5 mmol/L according CCMB), and record in the appropriate log that the clinician was notified. 
2015, second exercise
Interpretative comments (Case report)
1. Measured and re-measured blood glucose from the same blood sample from an outpatient is 11.4 mmol/L. During venepuncture, the patient states that he has been fasting and is not taking any medications. In this situation, you would: a) proceed as if the test result were a critical value and promptly notify the physician. 20 (12.2) b) immediately contact the patient and repeat blood sampling, while also requesting more details about 'fasting'.
(4.9)
c) verify the laboratory test results and refer the patient to a specialized facility for diabetes.
(1.2)
d) without verifying the laboratory test result, contact the patient and try to determine possible causes of hyperglycaemia.
(1.8)
e) verify the laboratory test result and include a comment to repeat blood glucose testing using a different sample and to check glucose in urine. 
Comment: Non-compliant answer d) .
PT -prothrombin time; INR -international normalized ratio; CCMB -Croatian Chamber of Medical Biochemists; TAT -turnaround time.
stantial variation in how they responded to certain questions about critical values; many lacked knowledge about age-dependent critical values and how to establish an intra-laboratory list of critical values.
The questionnaire presented respondents with three scenarios involving interpretative comments in order to understand to what extent medical laboratories in Croatia take an active role in interpreting test results and communicating those interpretations to clinicians orally or in writing. While laboratories varied in their responses to these scenarios, one third selected answers implying an active role in interpretation of test results, either via a comment written on the report or contact with the clinician and/or patient. In various situations, up to a third of laboratories issued results without additional activities.
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The last group of questions asked laboratories how they proceed in the event of abnormal test results. For example, does the laboratory repeat the test and, if so, does it use the same or a new sample? Is the sample re-analysed using the same test procedure as before or a different procedure? After re-testing, are the initial and/or follow-up test results shown on the final report? Most laboratories reported that they repeat testing to verify abnormal results. Nevertheless, one third reported that they issue results without such verification.
Discussion
Harmonization and standardization of pre-and post-analytical phases of laboratory work are essential for good clinical care. Since 2007, ISO standard 15189 has included assessment of pre-and post-analytical phases of testing as one of the requirements for accreditation of medical laboratories (6). Nevertheless, many providers of EQA schemes do not systematically assess the post-analytical phase (2) . Since 2014, all medical laboratories in Croatia are required to participate in a national EQA scheme that includes post-analytical assessment. The present study aimed to assess the current state of laboratory compliance with the EQA scheme, as well as identify areas where clearer rules -or the first set of rules -need to be developed at the national level. This is an urgent problem, because only 11 of 198 (5.5%) registered medical laboratories in Croatia are ISO 15189 -accredited, and most are planning to enter the accreditation process soon (7) . In the present study, we retrospectively analysed the responses of medical laboratories to the Module 11 post-analysis questionnaire incorporated in the Croatian EQA exercises since 2014. This questionnaire focused on the four main quality control indicators of the post-analytical phase of testing. Our results indicate substantial heterogeneity in how medical laboratories in Croatia proceed in situations where no clear rules or guidelines exist.
TAT is a frequently used quality indicator: it is easily tracked through the laboratory informatics system, and ISO 15189 mandates that the TAT be established for each type of test, through consultation between laboratory and clinician (item 5.8.11) (6). One challenge with standardizing TATs across laboratories is that the definition of TAT can vary depending on whether the laboratory is a primary, secondary or tertiary facility and whether the test is routine, emergency or specialized (8, 9 A small proportion (12%) of respondent laboratories left open-ended comments to one or more of the questions; nearly all these comments were that their laboratory did not routinely encounter, or had never encountered, the scenario described in the question. This suggests that many laboratories feel they lack sufficient knowledge or experience to deal adequately with many post-analytical problems, despite the implementation of the Croatian EQA scheme. This suggests the need for greater training opportunities for medical laboratories in the country.
The present study presents a preliminary picture of the early stages of post-analytical EQA at the national level in Croatia. It is based on a sampling of medical laboratories from around the country and makes use of a questionnaire tailored to the logistical, clinical, and regulatory situation in Croatia. As with most questionnaire assessments, there is some risk that practices reported on the survey do not reflect actual practices in the respondent laboratory. To reduce this risk, we asked that the questionnaires be filled out by professional laboratory staff responsible for quality control. Another limitation of our study is that the response rate ranged from 81% to 90%, raising the possibility that our sample was biased. For example, perhaps laboratories that felt more confident about their knowledge and practices were more likely to respond to our survey. If this is true, then our study may underestimate the lack of alignment with post-analytical best practices, which only reinforces our conclusion that much more needs to be done to accelerate the harmonization of post-analytical procedures in Croatia. A third limitation is that the survey was not extensive enough to offer comprehensive insights into laboratory practices and attitudes. While this may have helped ensure a high response rate for the preliminary analysis here, future work may wish to look at these issues in greater detail.
In conclusion, assessment of post-analytical quality indicators such as TAT, critical values and interpretative comments are well recognized by both CCMB and ISO 15189, although clear definition of these terms, guidelines compliance and actions to be taken by laboratories are often incomprehensible. The results of Module 11 survey in Croatia highlights major obstacles to harmonization and standardization of post-analytical practices at national level. Future EQA exercises should reinforce the importance of filling out this survey.
